Table 1.
Patient Characteristics
| Adjuvant (n=45) | No adjuvant (n=56) | P value | Test | |
|---|---|---|---|---|
| Age | 57.6 ± 11.7 | 59.5 ± 9.5 | 0.37 | t test |
| Male sex | 39 (87) | 50 (89) | 0.69 | Pearson’s χ2 |
| Clinical T status | ||||
| cT1 | 0 | 1 (2) | ||
| cT2 | 9 (20) | 17 (30) | ||
| cT3 | 35 (78) | 37 (66) | 0.36 | Pearson’s χ2 |
| cT4 | 1 (2) | 0 | ||
| cTx | 0 | 1 (2) | ||
| Clinical N status | ||||
| cN0 | 12 (27) | 13 (23) | ||
| cN1 | 32 (71) | 39 (70) | ||
| cN2 | 1 (2) | 1 (2) | 0.63 | Pearson’s χ2 |
| cN3 | 0 | 2 (4) | ||
| cNx | 0 | 1 (2) | ||
| Mean ACE27 score | 1.02 ± 0.78 | 1.20 ± 0.99 | 0.34 | t test |
| Histological subtype | ||||
| Adenocarcinoma | 37 (82) | 48 (86) | ||
| Squamous cell | 3 (7) | 3 (5) | 0.89 | Pearson’s χ2 |
| Other | 5 (11) | 5 (9) | ||
Data are n (%) or mean ± SD